Skip to main content
. 2024 May 7;9(5):103373. doi: 10.1016/j.esmoop.2024.103373

Figure 1.

Figure 1

Oncology trial-specific diversity and inclusion guidance documents issued by the FDA. CNS, central nervous system; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; US FDA, United States Food and Drug Administration.